enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. US FDA approves nasal spray alternative to EpiPen for ... - AOL

   www.aol.com/news/us-fda-approves-first-nasal...

   (Reuters) -The U.S. Food and Drug Administration has approved ARS Pharmaceuticals' nasal spray as the first needle-free emergency treatment for potentially fatal allergic reactions. The spray ...

3. FDA approves first nasal spray to treat dangerous allergic ...

   www.aol.com/lifestyle/fda-approves-first-nasal...

   U.S. health officials on Friday approved a nasal spray to treat severe allergic reactions, the first needle-free alternative to shots like EpiPen. The Food and Drug Administration said it approved ...

4. How nasal sprays might be used in the future - AOL

   www.aol.com/lifestyle/nasal-sprays-future...

   Severe allergic reactions: A nasal spray to treat severe allergic reactions could become the first non-injection alternative to fast-acting treatments like EpiPen. The FDA recently declined to ...

5. Nasal spray - Wikipedia

   en.wikipedia.org/wiki/Nasal_spray

   Nasal sprays are used to deliver medications locally in the nasal cavities or systemically. They are used locally for conditions such as nasal congestion and allergic rhinitis. In some situations, the nasal delivery route is preferred for systemic therapy because it provides an agreeable alternative to injection or pills. Substances can be ...

6. Nasal administration - Wikipedia

   en.wikipedia.org/wiki/Nasal_administration

   Nasal sprays are locally acting drugs such as decongestants for cold and allergy treatment, whose systemic effects are usually minimal. Examples of systemically active drugs available as nasal sprays are migraine drugs , rescue medications for overdose and seizure emergencies, hormone treatments , nicotine nasal spray , and nasal vaccines such ...

7. Olopatadine/mometasone - Wikipedia

   en.wikipedia.org/wiki/Olopatadine/mometasone

   Drug Information Portal. U.S. National Library of Medicine. "Mometasone furoate". Drug Information Portal. U.S. National Library of Medicine. Clinical trial number NCT02631551 for "Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR) (GSP 301-301)" at ClinicalTrials.gov